Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Huazhong Univ Sci Technolog Med Sci ; 34(5): 626-633, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25318869

RESUMO

This study was aimed to establish a stable animal model of left ventricular hypertrophy (LVH) to provide theoretical and experimental basis for understanding the development of LVH. The abdominal aorta of male Wistar rats (80-100 g) was constricted to a diameter of 0.55 mm between the branches of the celiac and anterior mesenteric arteries. Echocardiography using a linear phased array probe was performed as well as pathological examination and plasma B-type natriuretic peptide (BNP) measurement at 3, 4 and 6 weeks after abdominal aortic constriction (AAC). The results showed that the acute mortality rate (within 24 h) of this modified rat model was 8%. Animals who underwent AAC demonstrated significantly increased interventricular septal (IVS), LV posterior wall (LVPWd), LV mass index (LVMI), cross-sectional area (CSA) of myocytes, and perivascular fibrosis; the ejection fraction (EF), fractional shortening (FS), and cardiac output (CO) were consistently lower at each time point after AAC. Notably, differences in these parameters between AAC group and sham group were significant by 3 weeks and reached peaks at 4th week. Following AAC, the plasma BNP was gradually elevated compared with the sham group at 3rd and 6th week. It was concluded that this modified AAC model can develop LVH, both stably and safely, by week four post-surgery; echocardiography is able to assess changes in chamber dimensions and systolic properties accurately in rats with LVH.


Assuntos
Aorta Abdominal/patologia , Modelos Animais de Doenças , Hipertrofia Ventricular Esquerda/patologia , Animais , Constrição Patológica/complicações , Ecocardiografia/métodos , Ensaio de Imunoadsorção Enzimática , Coração/fisiopatologia , Hipertrofia Ventricular Esquerda/sangue , Hipertrofia Ventricular Esquerda/etiologia , Masculino , Miocárdio/patologia , Peptídeo Natriurético Encefálico/sangue , Ratos Wistar , Fatores de Tempo
2.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 37(2): 169-176, 2021 Mar.
Artigo em Zh | MEDLINE | ID: mdl-34672155

RESUMO

Objective: To find out the relationship between the duration and amplitude of oscillatory breathing (OB) and their exercise capacity in patients with chronic heart failure (CHF) we did this study. Methods: Two hundred and thirty-seven CHF patients performed a maximum incremental upright cycle ergometry cardiopulmonary exercise testing (CPET). Respiratory gas exchange was measured on a breath-by-breath basis throughout the test. OB was defined as 3 or more continuous cycle fluctuations of ventilation during CPET, and the amplitude of VE oscillations exceed 25% of concurrent mean value. The CHF patients with OB (OB+) were divided into 3 sub-groups according to their Peak VO2. Group1 (mild OB+) Peak VO2 of ≥16 ml/min/kg, group 2 (moderate OB+) Peak VO2 is between 12~16 ml/min/kg, group 3 (severe OB+) Peak VO2 ≤ 12 ml/(min·kg). Results: There were 78(32.6%) patients detected as OB+ in 237 CHF patients. Among OB+ patients, OB duration in s related negatively to Peak VO2 in mL/min/kg (r=-0.82), Peak VO2 in %pred (r=-0.65), VO2 at AT (r=-0.78), and related positively to VE/VCO2 at AT (r=0.61). Conclusion: OB duration is related negatively to exercise capacity of CHF patients.


Assuntos
Exercício Físico , Insuficiência Cardíaca , Doença Crônica , Teste de Esforço , Humanos , Respiração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA